Back­ing Bio­gen, 75+ House Re­pub­li­cans call on CMS to aban­don its de­ci­sion to lim­it amy­loid-tar­get­ed Alzheimer's drugs to tri­als

Top Re­pub­li­cans are call­ing on HHS “to aban­don and re-pro­pose” a draft na­tion­al cov­er­age de­ci­sion from CMS on an­ti-amy­loid Alzheimer’s drugs, which seeks to re­strict the use of such drugs to clin­i­cal tri­als un­til their ben­e­fits can be es­tab­lished.

Cathy Mc­Mor­ris Rodgers (WA), Kevin Brady (TX), Brett Guthrie (KY), and 75 oth­ers in the House sent a let­ter Wednes­day to HHS Sec­re­tary Xavier Be­cer­ra, urg­ing him to in­stead pro­vide “rea­son­able ac­cess to FDA-ap­proved [Alzheimer’s] treat­ments for a broad­er pop­u­la­tion of Medicare ben­e­fi­cia­ries.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER